2|0|Public
5000|$|<b>Lavoltidine</b> (previously {{known as}} loxtidine) â€” a similar {{compound}} in which methylsulfone group is replaced with hydroxyl ...|$|E
50|$|<b>Lavoltidine</b> (INN, USAN, BAN; {{previously}} {{known as}} loxtidine, code name AH-23,844) {{is a highly}} potent and selective H2 receptor antagonist which was under development by Glaxo Wellcome (now GlaxoSmithKline) {{as a treatment for}} gastroesophageal reflux disease but was discontinued due to the discovery that it produced gastric carcinoid tumors in rodents.|$|E

